Understanding Portal Vein Thrombosis: Risk Factors and Treatment
Author Information
Author(s): Sogaard Kirstine K, Astrup Lone B, Vilstrup Hendrik, Gronbaek Henning
Primary Institution: Aarhus University Hospital
Hypothesis
What are the risk factors, clinical presentation, complications, and treatment outcomes for portal vein thrombosis?
Conclusion
Most patients had a combination of local and systemic risk factors for PVT, and those treated with anticoagulation therapy had better outcomes.
Supporting Evidence
- 87% of patients had one or more risk factors for portal vein thrombosis.
- Patients treated with anticoagulant therapy had higher rates of recanalization.
- The overall mortality rate was 13% within one year.
Takeaway
Portal vein thrombosis is a condition where a blood clot forms in the vein that carries blood to the liver, and treating it with certain medications can help patients get better.
Methodology
This retrospective study analyzed data from 67 patients diagnosed with portal vein thrombosis between 1992 and 2005.
Potential Biases
Potential bias due to the single-center design and retrospective data collection.
Limitations
The study's retrospective nature limits generalizability, and it lacks large-scale randomized trials due to the rarity of the condition.
Participant Demographics
The study included 67 patients, with 23 women and 44 men, aged 15 to 78 years.
Statistical Information
P-Value
p<0.05
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website